LNCARSR and renal cell carcinoma: In discovery set, rs1417080 in lncARSR was significantly associated with RCC risk (P = 0.032, OR = 1.44, 95% CI = 1.03‐2.02 in dominant model) and risk was found in individuals with heterozygote TC genotype (P = 0.024, OR = 1.49, 95% CI = 1.05‐2.10 in codominant model).